Viemed Healthcare (NASDAQ:VMD) Director Timothy Smokoff Sells 20,000 Shares

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) Director Timothy Smokoff sold 20,000 shares of the business’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the completion of the sale, the director directly owned 75,518 shares of the company’s stock, valued at approximately $868,457. This trade represents a 20.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Viemed Healthcare Stock Down 0.5%

Viemed Healthcare stock opened at $11.63 on Friday. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $11.88. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. The company has a market capitalization of $445.86 million, a P/E ratio of 31.43 and a beta of 1.12. The stock has a 50-day simple moving average of $9.91 and a 200-day simple moving average of $8.84.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.The firm had revenue of $75.41 million for the quarter, compared to analysts’ expectations of $74.40 million. Equities research analysts expect that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.

Institutional Trading of Viemed Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the business. State of Alaska Department of Revenue acquired a new stake in Viemed Healthcare during the 4th quarter worth $25,000. Kemnay Advisory Services Inc. acquired a new position in Viemed Healthcare in the fourth quarter valued at $46,000. Quarry LP purchased a new stake in shares of Viemed Healthcare in the third quarter valued at about $48,000. AQR Capital Management LLC purchased a new stake in shares of Viemed Healthcare in the first quarter valued at about $90,000. Finally, SG Americas Securities LLC acquired a new stake in shares of Viemed Healthcare during the fourth quarter worth about $101,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.

Further Reading

Insider Buying and Selling by Quarter for Viemed Healthcare (NASDAQ:VMD)

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.